circ_PTN contributes to -cisplatin resistance in glioblastoma via PI3K/AKT signaling through the miR-542-3p/PIK3R3 pathway

Glioblastoma has been identified as the most common and aggressive primary brain tumor in adults. Recently, it has been found that cisplatin (DDP) treatment is a common chemotherapeutic method for GBM patients. circ_PTN (ID number: hsa_circ_0003949) is a newly found circular (circRNA) which has been...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Hongcheng Luo, Tingzhuang Yi, Deyou Huang, Xiaoping Chen, Xu Li, Qianquan Wan, Haineng Huang, Huadong Huang, Hongyu Wei, Ye Song, Tianshi Que, Rentong Hu, Huatuo Huang, Kunxiang Luo, Chuanyu Li, Chengjian Qin, Chuanhua Zheng, Chuanliu Lan, Wencheng Chen, Dan Zhou, Qisheng Luo
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2021-12-01
Serija:	Molecular Therapy: Nucleic Acids
Teme:	circ_PTN miR-542-3p PIK3R3 cisplatin-resistance glioblastoma PI3K/AKT signaling
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2162253121002298
Oznake:	Označite Brez oznak, prvi označite!